A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.
Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
Participant gender:
Summary
This study was designed to determine the long-term safety of asoprisnil 10 mg in women with
one or more uterine fibroids after an initial 12 weeks in study M99-144.